For many clinical trials, the enrollees may receive compensation for their participation – money or reimbursement of expenditure. For a study, the compensation may be activity-wise depending on their participation for all or limited number of activities. And, it can be decided in the Protocol even before the study begins that compensation be for entire study or activity-wise. Compensation is also subject to audit and review by Ethics Committee and/or Regulatory bodies.
Voluntary Informed consent plays a vital role in financial compensation which emphasizes the elimination of coercive nature and undue advantage and influence for the said study.
Keeping in mind the complexity of studies – right from volunteer enrolment, them competent enough for the study, also, completing the entire study and so many other challenges; over and above maintaining good practices throughout, Sarjen has included the compensation module designed such that compliance is not compromised.